Frizzled receptors (FZDs) in Wnt signaling: potential therapeutic targets for human cancers
- PMID: 38632318
- PMCID: PMC11272778
- DOI: 10.1038/s41401-024-01270-3
Frizzled receptors (FZDs) in Wnt signaling: potential therapeutic targets for human cancers
Abstract
Frizzled receptors (FZDs) are key contributors intrinsic to the Wnt signaling pathway, activation of FZDs triggering the Wnt signaling cascade is frequently observed in human tumors and intimately associated with an aggressive carcinoma phenotype. It has been shown that the abnormal expression of FZD receptors contributes to the manifestation of malignant characteristics in human tumors such as enhanced cell proliferation, metastasis, chemotherapy resistance as well as the acquisition of cancer stemness. Given the essential roles of FZD receptors in the Wnt signaling in human tumors, this review aims to consolidate the prevailing knowledge on the specific status of FZD receptors (FZD1-10) and elucidate their respective functions in tumor progression. Furthermore, we delineate the structural basis for binding of FZD and its co-receptors to Wnt, and provide a better theoretical foundation for subsequent studies on related mechanisms. Finally, we describe the existing biological classes of small molecule-based FZD inhibitors in detail in the hope that they can provide useful assistance for design and development of novel drug candidates targeted FZDs.
Keywords: FZD inhibitors; Frizzled receptors; Wnt signaling pathway; cancer therapy; structural foundation.
© 2024. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Frizzleds act as dynamic pharmacological entities.Trends Pharmacol Sci. 2024 May;45(5):419-429. doi: 10.1016/j.tips.2024.03.003. Epub 2024 Apr 8. Trends Pharmacol Sci. 2024. PMID: 38594145 Review.
-
Evolutionary conservation and cancer implications of the WNT signaling pathway.Med Oncol. 2025 Aug 20;42(10):434. doi: 10.1007/s12032-025-02950-8. Med Oncol. 2025. PMID: 40833535 Review.
-
Systemic treatments for metastatic cutaneous melanoma.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2. Cochrane Database Syst Rev. 2018. PMID: 29405038 Free PMC article.
-
A novel drug prejudice scaffold-imidazopyridine-conjugate can promote cell death in a colorectal cancer model by binding to β-catenin and suppressing the Wnt signaling pathway.J Adv Res. 2025 Jun;72:615-632. doi: 10.1016/j.jare.2024.07.022. Epub 2024 Jul 25. J Adv Res. 2025. PMID: 39067696 Free PMC article.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
Cited by
-
Wnt/Ca2+ signaling: Dichotomous roles in regulating tumor progress (Review).Oncol Lett. 2025 Jun 18;30(2):399. doi: 10.3892/ol.2025.15145. eCollection 2025 Aug. Oncol Lett. 2025. PMID: 40606304 Free PMC article. Review.
-
Unraveling the Role of the Wnt Pathway in Hepatocellular Carcinoma: From Molecular Mechanisms to Therapeutic Implications.J Clin Transl Hepatol. 2025 Apr 28;13(4):315-326. doi: 10.14218/JCTH.2024.00401. Epub 2025 Jan 14. J Clin Transl Hepatol. 2025. PMID: 40206274 Free PMC article. Review.
-
Anthraquinones from Rheum officinale Ameliorate Renal Fibrosis in Acute Kidney Injury and Chronic Kidney Disease.Drug Des Devel Ther. 2025 Jul 6;19:5739-5760. doi: 10.2147/DDDT.S521265. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40657042 Free PMC article. Review.
-
Pharmacological modulation of stem cells signaling pathway for therapeutic applications.Stem Cell Res Ther. 2025 Jul 1;16(1):327. doi: 10.1186/s13287-025-04438-8. Stem Cell Res Ther. 2025. PMID: 40598543 Free PMC article. Review.
-
Empagliflozin improves pressure-overload-induced cardiac hypertrophy by inhibiting the canonical Wnt/β-catenin signaling pathway.Front Pharmacol. 2024 Nov 27;15:1499542. doi: 10.3389/fphar.2024.1499542. eCollection 2024. Front Pharmacol. 2024. PMID: 39664517 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical